FBIO — Fortress Biotech, Inc.
Fortress Biotech, Inc. , a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $75.7M
- P/E Ratio
- 9.62
- Beta
- 1.45
- 52-Week Range
- 1.45-4.53
- Dividend Yield
- $0.00
- CEO
- Lindsay Allan Rosenwald
- Employees
- 101
- IPO Date
- Nov 17, 2011
- Exchange
- NASDAQ